The concept of metabolically healthy obesity has long divided the field. Some individuals with elevated body mass index maintain normal blood pressure, glucose metabolism and blood lipids, while others with the same degree of excess weight develop hypertension, dysglycemia and dyslipidemia. Whether the healthy phenotype is a stable state or merely an early stage on the road to disease remains contested, and the answer matters enormously for screening and prevention. Asian populations complicate the picture further, because they develop obesity-related complications at lower body mass index thresholds than European populations, which is why the study used the Asian-specific cutoff of 23 kilograms per square meter rather than the World Health Organization’s global threshold of 25. Healthcare workers, paradoxically, show higher rates of obesity than the general population despite their medical knowledge, making them an instructive group in which to study the transition from apparent health to metabolic dysfunction.

The research team recruited 297 employees of an urban Malaysian academic medical centre through voluntary convenience sampling. Eligible participants had a body mass index of at least 23 kilograms per square meter and no known cardiometabolic disease, meaning the cohort represented people who would typically pass an occupational health check without raising alarms. Each participant underwent a detailed anthropometric assessment, including neck circumference, waist circumference and hip circumference, alongside bioelectrical impedance analysis, a technique that estimates body composition by measuring how the body resists a weak electrical current. Because fat-free mass, which is largely muscle and water, conducts electricity well while fat resists it, the method can partition body weight into fat mass and fat-free mass with reasonable accuracy for population studies. Blood pressure, fasting glucose and lipid profiles completed the picture, allowing the researchers to classify each person as metabolically healthy or unhealthy.

The classification criteria were strict. Metabolically healthy overweight or obesity, abbreviated MHOO, required the complete absence of any metabolic abnormality: no dysglycemia, no elevated blood pressure and no dyslipidemia. Anyone with even one of these features was classified as metabolically unhealthy overweight or obesity, or MUOO. By this standard, only 100 of the 297 participants, or 33.67 percent, qualified as metabolically healthy. The proportion shrank as body mass index rose. At the obesity threshold of 30 kilograms per square meter, 85.32 percent of participants were metabolically unhealthy. Elevated blood pressure emerged as the predominant abnormality, a finding with particular relevance for Asian populations, in which hypertension-related cardiovascular disease often develops at lower body mass indices than in other groups.

When the researchers compared the two phenotypes, the metabolically unhealthy group carried both more fat mass and more fat-free mass than their healthier counterparts. That second observation is the more intriguing one, because fat-free mass expansion is often assumed to be benign or even protective. The correlation analysis revealed a clear division of labour among the simple measurements. Body mass index, waist circumference, hip circumference and waist-to-height ratio all correlated strongly with fat mass, with Spearman coefficients ranging from 0.75 to 0.93, confirming that these indices essentially track how much fat a person carries. Neck circumference and waist-to-hip ratio, by contrast, correlated better with fat-free mass, with coefficients of 0.68 and 0.41 respectively. Neck circumference also showed a moderate correlation of 0.44 with the triglyceride-glucose index, an insulin-resistance marker calculated from fasting triglycerides and glucose that has gained popularity as a cheap surrogate for more invasive metabolic testing.

To determine which measurements independently predicted metabolic status, the team built multivariable logistic regression models adjusted for sociodemographic factors, body composition metrics and the other anthropometric indices. After all adjustments, only neck circumference retained a modest but statistically significant association with metabolically unhealthy status, with an adjusted odds ratio of 1.15 per unit increase and a 95 percent confidence interval of 1.01 to 1.32. The association weakened when the triglyceride-glucose index was added to the model, a pattern that suggests neck circumference may act partly through insulin resistance rather than as an independent risk marker. In other words, a thicker neck may not itself cause metabolic disease, but it appears to flag the same underlying physiology that drives it.

The exploratory mediation analyses pushed this interpretation further. Using parallel mediation models, the researchers tested whether fat mass and fat-free mass explained the link between anthropometric measurements and metabolic risk. Both expansions of fat and lean mass appeared to mediate the association, but the pattern of correlations hinted at something more specific: a predilection for upper-body expansion of fat-free mass may be linked with metabolically unhealthy obesity. This is where the neck measurement earns its place at the table. The neck houses not only subcutaneous fat but also substantial muscle and other lean tissue, and upper-body fat depots are metabolically more active and more harmful than those in the lower body. Fat stored in and around the trunk and upper body drains directly into the portal circulation, flooding the liver with free fatty acids and promoting insulin resistance, whereas gluteofemoral fat is comparatively protective. If neck circumference captures upper-body lean tissue expansion along with fat, it may serve as a composite marker of a metabolically adverse body composition pattern that waist measurements alone miss.

The technical details matter for anyone hoping to translate these findings into practice. Bioelectrical impedance, while convenient and inexpensive, estimates rather than directly measures body composition, and its accuracy varies with hydration status and body geometry. Computed tomography and magnetic resonance imaging remain the gold standards for quantifying visceral fat and regional muscle mass, but they are impractical for population screening. The triglyceride-glucose index, like neck circumference, is attractive precisely because it costs almost nothing to obtain. The study’s cross-sectional design also imposes limits: it captures a single moment in time, so it cannot establish whether neck circumference predicts the future development of diabetes or cardiovascular disease, only that it is associated with current metabolic status. The authors themselves describe the mediation findings as exploratory and call for confirmation in larger cohorts, and the convenience sampling of healthcare workers at a single urban centre may limit generalizability, particularly since healthcare workers differ from the general population in activity levels, health literacy and access to care.

Even with those caveats, the study carries a message that resonates well beyond Malaysian hospitals. Metabolic disturbance is common among people who consider themselves healthy and who would rarely be screened aggressively, because they carry excess weight but no diagnosis. Elevated blood pressure, the most frequent abnormality in this cohort, is both silent and treatable, which makes finding it early genuinely consequential. The study also challenges the comfortable narrative that muscle mass is always protective. Fat-free mass expansion, at least when concentrated in the upper body, may travel alongside insulin resistance rather than against it, a nuance that could reshape how clinicians interpret body composition data from impedance scales increasingly found in gyms and clinics.

For now, the practical takeaway is modest but concrete. A tape measure around the neck, a measurement that takes seconds and requires no laboratory, may help clinicians identify patients with overweight or obesity who deserve closer metabolic scrutiny, especially in Asian populations where risk arrives at lower body mass indices. The researchers, led by Quan-Hziung Lim and Lee-Ling Lim of Universiti Malaya, published their work open access so that other teams can test the hypothesis in larger and more diverse cohorts. If the neck circumference signal survives that scrutiny, one of medicine’s simplest instruments may gain a new role in the fight against two of its most burdensome diseases. Until then, the study stands as a reminder that the body’s metabolic story is written in more places than the waistline, and that some of those places are hiding in plain sight, just below the chin.

Subject of Research: Anthropometric and body composition determinants of metabolically healthy versus unhealthy overweight/obesity in Malaysian healthcare workers

Article Title: Anthropometric and body composition determinants of metabolically healthy and unhealthy overweight/obesity: an analysis among Malaysian healthcare workers

Article References: Lim, Q.-H., Packrisamy, D., Ong, J. S., Kang, M. L., Hee, N. K. Y., Sarvanandan, T., Ooi, Y. G., Khoo, J. K., Ratnasingam, J., Vethakkan, S. R., & Lim, L.-L. (2026). Anthropometric and body composition determinants of metabolically healthy and unhealthy overweight/obesity: an analysis among Malaysian healthcare workers. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02530-5

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02530-5

Keywords: obesity, metabolic syndrome, neck circumference, body composition, anthropometry, insulin resistance, hypertension, bioelectrical impedance, fat-free mass, triglyceride-glucose index, Malaysia, healthcare workers

Osteosarcopenic adiposity, abbreviated OSA, describes the coexistence of three normally separate problems: reduced bone density (osteopenia or osteoporosis), age-related loss of muscle mass and strength (sarcopenia), and excess or abnormally redistributed body fat. The concept matters because these tissues are not independent players. Bone, muscle, and fat communicate through shared hormonal, inflammatory, and mechanical pathways, and deterioration in one can accelerate decline in the others. Fat that invades muscle and even bone marrow is increasingly recognized not as a passive storage depot but as an active secretory organ that promotes chronic low-grade inflammation, insulin resistance, and catabolic signaling. When all three tissues fail together, the result is a vicious cycle of fragility, falls, fractures, and metabolic disease. Yet despite growing interest in the phenotype, the timing of its emergence—and whether it looks different in men and women—has remained poorly defined.

To address that gap, the team turned to LOESS, or locally estimated scatterplot smoothing, a nonparametric regression technique that fits flexible curves to data without imposing a predefined mathematical relationship between age and each body composition outcome. This is a crucial methodological choice. Traditional analyses often assume linear or simple polynomial declines, which can mask the true inflection points where tissue loss accelerates or decelerates. By letting the data speak, LOESS revealed the actual bends in the aging curves. The researchers also conducted sensitivity analyses, refitting all curves with varying stiffness parameters and computing confidence intervals, to ensure the identified inflection points were robust rather than artifacts of a particular smoothing setting. Prespecified operational thresholds for BIA-ACC-derived bone and muscle mass scores, along with sex-specific fat mass percentages, were used to classify participants as having reduced bone mass, reduced muscle mass, adiposity, or the combined OSA phenotype.

The sex differences were unmistakable. Men reached their peaks in bone and muscle mass earlier in life and then enjoyed a period of relative stability through midlife, before declining to lower values in later life than women of the same age. Women, by contrast, started adulthood with lower baseline bone and muscle values and displayed multiple inflection points early in life, suggesting a more turbulent developmental and early-adult trajectory. The most dramatic feature of the female curves was a sharp midlife downturn, particularly around the time of menopause—a pattern consistent with decades of research linking the loss of estrogen to accelerated bone resorption and adverse changes in muscle and fat distribution. Estrogen’s protective effects on bone remodeling and musculoskeletal performance are well documented, and the new curves provide a population-level visualization of exactly when that protection appears to be withdrawn.

Fat told a different story in each sex. In men, fat mass increased steadily and almost monotonically across adulthood, a slow and relentless accumulation with no dramatic inflection points. In women, fat mass followed multiphasic patterns, rising and falling in distinct phases across the life course, likely reflecting the interplay of reproductive hormones, childbearing years, and the menopausal transition. Intramuscular adipose tissue, however, behaved more uniformly: it increased progressively with age in both men and women, making fatty infiltration of muscle one of the most consistent markers of musculoskeletal aging in the dataset. This finding carries clinical weight, because IMAT is associated with impaired muscle quality, reduced mobility, and metabolic dysfunction, and it may represent an early warning sign that precedes overt losses of bone and muscle mass.

Perhaps the most sobering result concerned participants who met the operational BIA-ACC criteria for the OSA phenotype. These individuals were identified even among the youngest participants in the cohort, indicating that the triad of low bone mass, low muscle mass, and excess adiposity is not exclusively a disease of old age. Adults meeting the OSA criteria demonstrated less stable body composition trajectories overall, with earlier downturns in their bone and muscle components and more complex patterns in fat and intramuscular fat. In other words, the phenotype appears to mark a subgroup whose tissues begin declining ahead of schedule, compounding one another’s deterioration decades before the typical fragility window. The authors suggest that early identification of this phenotype could support preventive assessment of accelerated musculoskeletal decline and rising adiposity, potentially opening a window for intervention long before fractures or disability occur.

The study’s cross-sectional design warrants careful interpretation. Because each participant was measured at a single point in time, the curves represent differences between age groups rather than changes tracked within the same individuals over decades. Cohort effects—differences in nutrition, physical activity, and medical care between generations—could contribute to some of the observed patterns. Longitudinal studies, such as the Health, Aging and Body Composition Study cited by the authors, have documented long-term rates of change in musculoskeletal aging, and future work combining longitudinal follow-up with the inflection-point approach used here would strengthen causal inference. The cohort was also limited to Caucasian adults, and body composition norms and OSA prevalence may differ across ancestry groups, so generalization to other populations requires caution. Additionally, BIA-ACC, while nonionizing and suitable for very large samples, estimates rather than directly images tissue compartments; dual-energy X-ray absorptiometry and quantitative CT remain reference standards for bone and fat depots, and prior comparative work has examined bioimpedance against DEXA in postmenopausal women.

Even with those caveats, the scale and granularity of the analysis make it a valuable contribution to the biology of aging. The findings align with a broader shift in gerontology away from viewing aging as a smooth, uniform process and toward recognizing nonlinear dynamics, with molecular studies now identifying waves of change at specific ages across multiple organ systems. The menopause-related inflection in women’s bone and muscle curves echoes established clinical knowledge about postmenopausal osteoporosis, but the demonstration that men’s later-life values fall below women’s—despite their earlier, higher peaks—adds nuance to the conventional narrative that women are uniformly more vulnerable to musculoskeletal decline. It also underscores that men’s steady fat gain and progressive muscle fat infiltration deserve attention in their own right, particularly given the links between adipose tissue dysfunction, insulin resistance, and chronic disease.

For clinicians and the public, the practical takeaway is that the timing of risk is sex-specific and measurable. Women’s preventive efforts around bone and muscle may need to intensify in the years surrounding menopause, when the curves bend most sharply, while men’s risk profile may accumulate more insidiously through midlife fat gain and later-life tissue loss. Screening tools that can flag the OSA phenotype early—ideally nonionizing, inexpensive, and scalable, as bioimpedance-based approaches aim to be—could help identify people whose trajectories are already diverging from healthy aging. As the authors conclude, distinct sex-specific patterns exist, and the adverse association between the OSA phenotype and body composition trajectories suggests that catching this combined deterioration early may be one of the most effective strategies for preserving mobility, preventing fractures, and extending healthspan across the second half of life.

Subject of Research: Sex- and age-specific changes in bone, muscle, and fat mass across adulthood and their relation to the osteosarcopenic adiposity phenotype

Article Title: Sex- and age-specific patterns in bone, muscle, and fat across adulthood and their relation to osteosarcopenic adiposity phenotype: a cross-sectional study

Article References: Ilich, J. Z., Mills, J., Cvijetic, S., Barlow, E. M., Galijasevic, S., Boschiero, D., & Harman, J. (2026). Sex- and age-specific patterns in bone, muscle, and fat across adulthood and their relation to osteosarcopenic adiposity phenotype: a cross-sectional study. GeroScience. https://doi.org/10.1007/s11357-026-02496-1

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02496-1

Keywords: aging, body composition, osteosarcopenic adiposity, sarcopenia, osteoporosis, intramuscular fat, menopause, bioelectrical impedance, LOESS regression, sex differences, bone health, adiposity

The international research team, drawing on data from Taiwan and Japan, has developed and validated the first population-based prediction equations for estimating appendicular skeletal muscle mass, or ASM, specifically calibrated for Asian bodies. The work is notable not only for its scale, encompassing 13,582 adults across three major cohorts, but also for its practical payoff: the best-performing equation estimates a person’s arm and leg muscle mass using nothing more than age, sex, height and weight. No scanner, no blood draw, no specialized equipment. For the vast majority of community clinics in Asia, where dual-energy X-ray absorptiometry (DXA) machines and bioelectrical impedance devices remain scarce, that simplicity could transform sarcopenia screening from an occasional hospital referral into a routine part of every health check-up.

The diagnostic challenge the study addresses is rooted in how sarcopenia is defined. Both the European Working Group on Sarcopenia in Older People and the Asian Working Group for Sarcopenia place muscle mass at the core of diagnosis. The gold-standard tools, however, are cumbersome. Magnetic resonance imaging and computed tomography distinguish intramuscular fat from contractile tissue with unmatched precision but are far too expensive and inaccessible for population screening. DXA, which measures lean soft tissue in the limbs, is the routine clinical standard but is concentrated in hospitals. Bioelectrical impedance analysis is portable yet suffers from accuracy problems that vary by device, method and ethnicity. Prediction equations derived from the United States National Health and Nutrition Examination Survey (NHANES) had shown excellent performance in Western populations, with R-squared values of 0.89 to 0.91, but the researchers suspected they would falter in Asia.

That suspicion was grounded in well-documented biology. Body composition and anthropometric profiles differ substantially between Asian and Western populations, and even the trajectory of age-related muscle loss differs. Western studies report significant muscle decline after age 50 in both sexes, whereas research from Taiwan, Japan, Korea and Hong Kong shows that Asian women tend to maintain their muscle mass until roughly age 80. Extrapolating Western equations to Asian cohorts, the team reasoned, could introduce systematic errors precisely where diagnostic accuracy matters most.

To test that hypothesis and fill the gap, the investigators designed a rigorous three-phase validation framework. Phase 1 externally validated four existing NHANES-derived equations across three cohorts: the I-Lan Longitudinal Aging Study (ILAS) from Taiwan with 2,780 participants, the Nutrition and Health Survey in Taiwan (NAHSIT) with 6,853 participants, and Japan’s National Institute for Longevity Sciences-Longitudinal Study of Aging (NILS-LSA) with 3,949 participants. In every case, muscle mass had been measured by DXA, defined as the sum of lean soft tissue in all four limbs, and low muscle mass was classified using the AWGS 2019 thresholds of less than 7.0 kilograms per square meter for men and less than 5.4 for women.

The Phase 1 results confirmed both the promise and the limits of the imported equations. Performance varied across cohorts, with R-squared values ranging from a modest 0.52 in ILAS for the weakest equation to a strong 0.89 in NAHSIT for the best. Equation 4 from the NHANES set consistently performed best, achieving the lowest root mean square error in ILAS (1.88) and NAHSIT (1.52), while Equation 6 excelled in the Japanese cohort with an RMSE of 1.45. Diagnostic discrimination was respectable, with areas under the receiver operating characteristic curve reaching 0.91 in men and 0.89 in women in the Taiwanese national survey. But the variability across populations signaled that a one-size-fits-all approach borrowed from Western data was not good enough.

Phase 2 therefore built new Asian-specific equations from scratch using the NAHSIT cohort, the largest and most demographically diverse of the three, which included adults of all ages with 21.2 percent under 40. The team log-transformed candidate variables, including age, sex, height, weight and routine blood and urine markers, and used univariate, multivariate and stepwise regression to select predictors. Judged by R-squared, the Akaike information criterion and the Bayesian information criterion, the winning model retained only log age, sex, log height and log weight. The final Equation 4, fitted to the full dataset, takes the form ASM = 0.01926437 × age^(−0.065719) × 0.832924731^(Female) × Weight^(0.698532) × Height^(0.841383), a compact multiplicative formula that any spreadsheet can evaluate.

Its performance was exceptional. Within NAHSIT, the equation achieved an R-squared of 0.90, an RMSE of 1.45 and a median prediction error of just 0.06 kilograms, with no systematic or proportional bias on Bland-Altman analysis. For detecting low muscle mass under AWGS 2019 criteria, it reached an area under the curve of 0.90 in both sexes, with sensitivity of 0.85 and specificity of 0.80 in men and sensitivity of 0.87 and specificity of 0.80 in women. Correlations between estimated and measured skeletal muscle index stood at 0.82 for both sexes. Then came the decisive test: Phase 3 applied the Taiwanese-derived equations to the independent Japanese NILS-LSA cohort, and the models held up. Equations 4 and 5 again achieved AUCs of 0.90 in men and 0.85 in women, with correlations between estimated and actual muscle index ranging from 0.75 to 0.84 and minimal bias, demonstrating genuine cross-population generalizability.

The clinical implications are immediate. Because Equation 4 requires only age, sex, height and weight, general practitioners, nurses and community health workers can screen for low muscle mass using data already collected at every routine check-up, without serum creatinine measurements or imaging. Early identification opens the door to timely referral, resistance exercise programs and nutritional support, the interventions proven to slow functional decline. The stakes are high: although 97.2 percent of Asian healthcare professionals are aware of sarcopenia, only 42.9 percent actually diagnose it in practice, largely because DXA and BIA access is limited. The study’s authors caution that their participants were community-dwelling adults, that the Japanese validation cohort excluded people under 40, and that different DXA systems were used across cohorts, though each model was developed and validated within a single cohort to preserve measurement consistency. Future work should extend validation to other Asian ethnicities and test whether the equations predict hard outcomes over time. For now, the message is clear: four numbers on a clipboard may be enough to catch a silent disease before it steals a person’s strength.

Subject of Research: Development and three-phase validation of population-based prediction equations for appendicular skeletal muscle mass in Asian adults

Article Title: Population‐Based Prediction Equations for Appendicular Skeletal Muscle Mass: A Three‐Phase Validation Study in 13 582 Asian Adults

Article References: Lai, H.-Y., Zhang, S., Chen, I.-T., Otsuka, R., Lee, W.-J., Liang, C.-K., Yen, K.-H., Arai, H., Hsiao, F.-Y., & Chen, L.-K. (2026). Population‐Based Prediction Equations for Appendicular Skeletal Muscle Mass: A Three‐Phase Validation Study in 13 582 Asian Adults. Journal of Cachexia, Sarcopenia and Muscle, 17(5), Article e70360. https://doi.org/10.1002/jcsm.70360

Image Credits: AI Generated

DOI: 10.1002/jcsm.70360

Keywords: sarcopenia, appendicular skeletal muscle mass, prediction equations, DXA, Asian Working Group for Sarcopenia, muscle mass screening, aging, Taiwan, Japan, NHANES, bioelectrical impedance, healthy longevity